GASTROESOPHAGEAL CANCER (GC)
Clinical trials for GASTROESOPHAGEAL CANCER (GC) explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL CANCER (GC) trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL CANCER (GC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug CTX-10726 tested for advanced cancers: hope for patients out of options
Disease control Recruiting nowThis early-phase study tests a new drug called CTX-10726 in people with advanced cancers (stomach, liver, uterine, or kidney) that have not responded to standard treatments. The main goal is to check the drug's safety and find the best dose. About 70 adults will take part, and th…
Matched conditions: GASTROESOPHAGEAL CANCER (GC)
Phase: PHASE1 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New drug combo targets genetic weakness in tough cancers
Disease control Recruiting nowThis early-stage study is testing a new drug, IDE892, both alone and in combination with another drug called IDE397. It is for adults with advanced solid tumors that have a specific genetic change called MTAP deletion and have stopped responding to standard treatments. The main g…
Matched conditions: GASTROESOPHAGEAL CANCER (GC)
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Apr 15, 2026 16:15 UTC